Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression

被引:18
|
作者
Shin, Jimin [1 ,2 ,3 ]
Song, In-Sung [1 ,2 ,3 ]
Pak, Jhang Ho [3 ]
Jang, Sung-Wuk [1 ,2 ]
机构
[1] Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea
基金
新加坡国家研究基金会;
关键词
EMT; Annexin A1; E-cadherin; EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER CELLS; SODIUM-BUTYRATE; PROSTATE-CANCER; SUPPRESSOR GENE; TUMOR-CELLS; DIFFERENTIATION; APOPTOSIS; PROGRESSION; METASTASIS;
D O I
10.1007/s13277-016-5306-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial to mesenchymal transition (EMT) is a critical step in the metastasis of epithelial cancer cells. Butyrate, which is produced from dietary fiber by colonic bacterial fermentation, has been reported to influence EMT. However, some studies have reported that butyrate promotes EMT, while others have reported an inhibitory effect. To clarify these controversial results, it is necessary to elucidate the mechanism by which butyrate can influence EMT. In this study, we examined the potential role of annexin A1 (ANXA1), which was previously reported to promote EMT in breast cancer cells, as a mediator of EMT regulation by butyrate. We found that ANXA1 mRNA and protein were expressed in highly invasive melanoma cell lines (A2058 and A375), but not in SK-MEL-5 cells, which are less invasive. We also showed that butyrate induced ANXA1 mRNA and protein expression and promoted EMT-related cell invasion in SK-MEL-5 cells. Downregulation of ANXA1 expression using specific small interfering RNAs in butyrate-treated SK-MEL-5 cells resulted in increased expression of the epithelial marker E-cadherin and decreased cell invasion. Moreover, overexpressing ANXA1 decreased the expression of the E-cadherin. Collectively, these results indicate that butyrate induces the expression of ANXA1 in human melanoma cells, which then promotes invasion through activating the EMT signaling pathway.
引用
收藏
页码:14577 / 14584
页数:8
相关论文
共 50 条
  • [11] Oxamflatin Induces E-cadherin Expression in HeLa Cervical Carcinoma Cells
    Faghihloo, Ebrahim
    Vala, Mojdeh Hakemi
    Eslami, Gita
    Goudarzi, Hossein
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2018, 13 (05):
  • [12] Hypotonic stress induces E-cadherin expression in cultured human keratinocytes
    Kippenberger, S
    Loitsch, S
    Guschel, M
    Müller, J
    Kauffman, R
    Bernd, A
    FEBS LETTERS, 2005, 579 (01): : 207 - 214
  • [13] EXPRESSION OF E-CADHERIN IN EMBRYOGENETIC INGRESSION AND CANCER INVASION
    MAREEL, M
    BRACKE, M
    VANROY, F
    VAKAET, L
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 1993, 37 (01): : 227 - 235
  • [14] E-CADHERIN EXPRESSION - A COUNTERBALANCE FOR CANCER CELL INVASION
    MAREEL, M
    VLEMINCKX, K
    VERMEULEN, S
    BRACKE, M
    VANROY, F
    BULLETIN DU CANCER, 1992, 79 (04) : 347 - 355
  • [15] SNAIL Regulates E-Cadherin Expression in Human Endometrial Cells
    Baez, Perla
    Ruiz, Abigail
    Colon, Mariearmen
    Salvo, Virgilio A.
    Flores, Idhaltz
    BIOLOGY OF REPRODUCTION, 2009, : 125 - 125
  • [16] TWIST1 upregulation affects E-cadherin expression in brain metastases
    P. Brlek
    A. Bukovac
    A. Kafka
    N. Pećina-Šlaus
    Clinical and Translational Oncology, 2021, 23 : 1085 - 1095
  • [17] Expression of connexin 43 and E-cadherin in choroidal melanoma
    Ying-Ying Mou 1
    International Journal of Ophthalmology, 2011, (02) : 156 - 161
  • [18] E-cadherin expression in lymph node metastatic melanoma
    Nikolaidou, A.
    Minotakis, D.
    Goupou, E.
    Manoloutsiou, I. Michalopoulou
    Tsioltas, D.
    VIRCHOWS ARCHIV, 2015, 467 : S48 - S48
  • [19] Expression of E-cadherin and associated molecules in malignant melanoma
    Ali-Khan, AS
    Intzedy, L
    Pignatelli, M
    JOURNAL OF PATHOLOGY, 2002, 198 : 40A - 40A
  • [20] TWIST1 upregulation affects E-cadherin expression in brain metastases
    Brlek, P.
    Bukovac, A.
    Kafka, A.
    Pecina-Slaus, N.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (06): : 1085 - 1095